The U.S. Department of Justice (DOJ) has initiated an investigation into venture capital firm Andreessen Horowitz (a16z) concerning potential antitrust violations related to its partners serving on the boards of competing companies. This probe centers on the firm’s involvement with Databricks and Fivetran, two companies that have evolved into competitors over time.
Ben Horowitz, co-founder of a16z, holds a board seat at Databricks, a company valued at $190 billion and renowned for its cloud storage solutions. Databricks has recently expanded into AI data pipelines and application connectors with its Lakeflow product. Meanwhile, a16z partner Martin Casado serves on the board of Fivetran, a company specializing in data integration services. The overlap in board memberships has raised concerns about potential conflicts of interest.
Section 8 of the Clayton Act, a law enacted in 1914, prohibits individuals from serving on the boards of competing companies to prevent anticompetitive practices. Historically, this statute has been infrequently applied to venture capital firms. The current investigation suggests a shift in regulatory focus, potentially signaling increased scrutiny of board memberships within the venture capital sector.
Industry insiders have expressed surprise at the DOJ’s actions. It’s noted that when a16z initially invested in Databricks and Fivetran, the two companies were not direct competitors. However, as both have expanded their product offerings, their business models have begun to overlap, leading to the current situation.
In response to potential conflicts, venture capital firms often implement measures such as establishing ‘Chinese walls’—internal information barriers—to prevent the exchange of sensitive information between partners involved with competing companies. In this case, a16z could separate the activities of Horowitz and Casado to mitigate concerns.
The outcome of this investigation could have significant implications for the venture capital industry. If the DOJ enforces stricter interpretations of antitrust laws regarding board memberships, it may lead to a reevaluation of how venture capital firms manage their investments and board representations. This could result in reduced board participation by VCs, potentially impacting corporate governance and oversight within startups.
As the situation unfolds, it will be crucial for venture capital firms to reassess their governance structures and ensure compliance with antitrust regulations to avoid similar scrutiny. The industry may need to adopt more stringent internal policies to navigate the evolving regulatory landscape effectively.
